Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUCCESS-1 phase 3 trial of SC0062 in proteinuric IgA nephropathy
CTR20244897Phase 3Active
- Sponsor
- Zhikang Hongyi
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SC0062 in IgA nephropathy (IgAN), sponsored by Zhikang Hongyi. Started Jan 2025; status: active.
02
Drugs
SC0062
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on CTR20244897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244897.